. For cytoplasmic DNA sensing, cGAS (cyclic GMP-AMP [cGAMP] synthase) (Sun et al., 2013) recognizes cytosolic double-stranded DNA and produces the second messenger cGAMP (Civril et al., 2013; Gao et al., 2013; to activate STING (stimulator of IFN genes, also named MITA/ERIS) (Ishikawa and Barber, 2008; Sun et al., 2009; Zhong et al., 2008) . Activation of PRRs leads to the activation of transcription factors NF-kB and interferon regulatory factor IRF3 and/or IRF7, and the production of various cytokines including type I-interferons (IFNs). Type I-IFNs induce the expression of hundreds of interferon-stimulated genes (ISGs), which interfere with almost every step of viral replication, resulting in the establishment of a cellular antiviral state. Transition metals such as iron (Fe), manganese (Mn), copper (Cu), and zinc (Zn) are essential for all forms of life, as 30% of enzymes require a metal cofactor (Hood and Skaar, 2012) . Clinical deficiency of either Fe or Zn in the host increases the incidence of infectious disease and mortality (Clark et al., 2016; Stacy et al., 2016) . Manganese is one of the most abundant metals in the tissues of mammals, ranging from 0.3 to 2.9 mg/kg wet tissue weight, and is required for a variety of physiological processes including development, reproduction, neuronal function, immune regulation, and antioxidant defenses (Horning et al., 2015; Kwakye et al., 2015) . Mn exerts its function by regulating various Mn-dependent enzymes, including oxidoreductases, isomerases, transferases, ligases, lyases, and hydrolases. It is also an essential component of some metalloenzymes such as Mn superoxide dismutase (SOD2), glutamine synthetase (GS), and arginase (Waldron et al., 2009) . Although Mn has been implicated in the host-bacteria interface (Corbin et al., 2008; Radin et al., 2016) , its function in innate immunity has never been reported.
We identified here a role of Mn 2+ in alerting cells to viral infection via sensitizing both cGAS and STING. Mn 2+ was liberated from membrane-enclosed organelles and accumulated in the cytosol, and bound to cGAS by increasing both the dsDNA sensitivity and the enzymatic activity of cGAS. Mn 2+ also promoted STING's activity through the enhanced cGAMP-STING binding affinity. The liberated cytosolic Mn 2+ thus lowered the detection limit of host cells to dsDNA and virus by several orders of magnitude. Consequently, Mn-deficient mice produced decreased amounts of cytokines and were more vulnerable to was a potent innate immune stimulator, inducing a type I-IFN response and cytokine production in the absence of any infection. Our results thus demonstrated that Mn is critically involved and required for the host defense against virus.
RESULTS
Increased Cytosolic Mn 2+ Levels Stimulate Cells into an Anti-Virus State During our daily experiments, we noticed repeatedly that cellular antiviral activity differed dramatically among distinct cell states under different culture conditions. We reasoned that some components in culture medium may influence such activity in cells. To search for potential factors involved, we focused on the basic components in the culture medium, including serum, carbohydrates, amino acids, vitamins, trace elements, fatty acids, and some metabolites and salts critical for cell growth. A human leukemia monocytic cell line, THP1, was pretreated with different amounts of each component for 24 hr before cells were infected with GFP-tagged vesicular stomatitis virus (VSV-GFP). After another 18 hr, cells were analyzed for viral infection by flow cytometry. The mean fluorescence intensity (MFI) of viral-GFP was used as an indicator of viral propagation (Figures S1A-S1E, concentrations of metabolite composition are listed in the Table S4 ). We found that Vitamin D 3 , a prehormone that is implicated in regulating the synthesis of hundreds of enzymes, restricted the propagation of viruses in a dose-dependent manner as indicated by the significantly reduced MFI of viral-GFP ( Figure 1A , indicated by *), which agreed with previous reports showing that vitamin D 3 is an antiviral agent against hepatitis C virus (HCV) in human hepatocytes (Abu-Mouch et al., 2011; Gal-Tanamy et al., 2011) . We also found that lower concentrations of fetal bovine serum (FBS) in culture medium made otherwise unresponsive tumor cells sensitive to cytosolic dsDNA and DNA viruses and that higher FBS concentrations abrogated such sensitivity in sensitive cells (Fang et al., 2017b; Wang et al., 2017) . However, we found that MnCl 2 -treated cells were almost completely resistant to VSV infection ( Figure 1B , indicated by *). To confirm this result and to exclude viral type specificity, MnCl 2 -treated THP1 cells were infected with distinct types of GFP-expressing viruses, either DNA viruses (Herpes simplex virus 1 [HSV-1] or RNA viruses (Newcastle disease [NDV] and VSV). We found that MnCl 2 -pretreated cells acquired resistance to all tested viruses ( Figure 1C ). We next tested this virus-resistant effect by adding different concentrations of Mn and observed that THP1 cells started to gain antiviral activity when the Mn 2+ level in medium reached 2 mM ( Figure 1D ), in which the propagation of HSV-1 and VSV was suppressed. Whereas 5 mM (for VSV) or 20 mM (for HSV-1 and NDV) of MnCl 2 inhibited virus infection, 50 mM of MnCl 2 essentially rendered cells complete protection from all the viruses ( Figures 1D and 1E ). The cytosolic Mn concentration, measured by Inductively Coupled Plasma Mass Spectrometry (ICP-MS) after MnCl 2 treatment, accumulated approximately to a concentration 10 times higher than that in the medium within 6-18 hr ( Figure S1F ). These data indicated that the elevated cytosolic manganese functions to inhibit viral infection.
To investigate the in vivo antiviral activity of MnCl 2 , mice were pre-exposed with MnCl 2 (1 or 2 mg/kg of MnCl 2 ) 18 hr before challenge with HSV-1, VSV, or Vaccinia virus (VACV). The survival of these virus-infected mice was significantly extended after MnCl 2 pretreatment: approximately one half of the pretreated mice were still alive when all the control mice were dead ( Figure 1F ), with markedly decreased virus titers in various organs ( Figure 1G ). These results together suggested that MnCl 2 induces an anti-virus state both in vitro and in vivo.
Mn
2+ Is Released from Membrane-Enclosed Organelles and Accumulates in the Cytosol upon Virus Infection To determine a possible physiological function of Mn 2+ in antiviral responses, we performed ICP-MS to measure the distribution of transition metals including Mn, Cu, and Zn during virus infection. Cell homogenates were centrifuged to separate the membrane fractions (Pellet) from the cytosolic fraction (S-100). This pellet thus contained most of the membrane-enclosed organelles. Analysis of S-100 and culture supernatants (Sup) revealed the steadily elevated levels of Mn, but not Cu or Zn, during virus infection (Figures 2A and S2A) . The cytosolic Mn level increased about 60-fold within 36 hr post infection, changing from 0.12 mmol/kg to 5.8 or 6.8 mmol/kg, responding to HSV-1 or VACV respectively, together with a continuous accumulation of extracellular soluble Mn ( Figures 2B and S2B) . Although VSV or SeV infection at an MOI of 0.01 only caused a marginal Mn release after 36 hr, higher MOI (from 0.05) or prolonged infection did cause Mn accumulation (data not shown and see below). Detailed analysis of Mn distribution in separate cellular organelles by differential centrifugations ( Figure S2C ) revealed the Mn accumulation in cytosol and the simultaneous decline in P-5 (containing some endoplasmic reticulum [ER] and the majority of mitochondria) and P-100 (containing the majority of ER and Golgi apparatus), indicating the release of Mn from these organelles ( Figures 2C and S2D) , which was consistent with previous results that most of the cellular Mn 2+ is kept in mitochondria and Golgi apparatus (Carmona et al., 2014; Martinez-Finley et al., 2013) . Cytosolic Mn accumulation was reversed once virus DNA synthesis was inhibited by acyclovir, an antiviral molecule used for the treatment of HSV and chickenpox (Figures 2D, S2E and S2F) . Previous work demonstrated that Mn 2+ is sequestered by the mitochondrial Ca 2+ uniporter that is energized by the membrane potential (Dc) (Gavin et al., 1990) and released from mitochondria by reverse uniport when Dc falls (Gunter et al., 1978) . Moreover, it has been reported that HSV-1 (Murata et al., 2000) and VACV (Humlová et al., 2002) potently disrupt Dc in host cells. Agreeing with these findings, HSV-1 and VACV infection resulted in a fast dissipation of mitochondrial membrane potential as indicated by the decreased JC-1-oligomer fluorescence ( Figure 2E ), which may account for the release of mitochondrial Mn 2+ into cytosol.
SeV or VSV also caused Dc dissipation at much higher virus doses ( Figure S2G ). Moreover, vesicle acidification followed by cytoplasmic acidification was observed during HSV-1 and VACV infection ( Figure 2F and data not shown), which is consistent with previous studies (Dai et al., 2014; Pavelin et al., 2013) . Such acidification was inhibited by acyclovir as well (Figure 2G) . The results that excessive Mn is retained intracellularly as insoluble manganese phosphate or manganese carbonate in organelles and that low pH condition triggers the solubilization and release of Mn 2+ Bragadin et al., 1983; Gunter et al., 2013) suggested an alternative Mn-releasing mechanism in cells upon virus infection. The increased Mn contents in bronchoalveolar lavage fluid (BALF), white blood cells (WBC), and alveolar macrophages from virus-infected mice confirmed the physiological relevance of the Mn extracellular release during virus infection ( Figures 2H and S2H) . These results collectively suggested that virus infection induces the cytosolic release and accumulation of Mn both in vitro and in vivo. 
D
Mn 2+ . The cell homogenates were centrifuged at 100,000 g for 60 min to separate cytosolic extracts (S100) and pellets (Pellet), or were sequentially centrifuged at 500 g for 15 min, 5,000 g for 30 min and 100,000 g for 60 min to obtain P0.5, P5, P100, and S100 cellular fractions. (H and I) Human PBMCs (10 5 /ml) were treated with MnCl 2 as indicated (H, 36 hr; I, 200 mM), followed by type I-IFN bioassay and western blot analysis.
MFI of GFP
(B, C, D, H, and I) One representative experiment of at least three independent experiments is shown, and each was done in triplicate. (E and G) Each dot point represents one independent biological replicate. Data are shown as mean ± SEM (n R 3). N.S., not significant, p > 0.05; *p < 0.05; ***p < 0.001. See also Figure S3 . (Kumar et al., 1997) didn't gain such resistance ( Figure S3D ). To investigate whether Mn 2+ functions similarly in vivo, organs and alveolar macrophages were collected from mice intranasally dropped with 1 mg/kg MnCl 2 . Robust cytokine induction in alveolar macrophages ( Figure 3E ) and ISG expression in lungs from MnCl 2 -treated mice ( Figure S3E ) were detected. Similar results were obtained when Mn 2+ was administrated intravenously. Type I-IFNs in the sera ( Figure S3F ) and ISG expression in organs from MnCl 2 -injected mice ( Figure 3F ) were detected. Peripheral blood mononuclear cells (PBMCs) from healthy human donors responded similarly to Mn 2+ in a time-and dose-dependent manner ( Figures 3G-3I ). These data collectively showed that Mn 2+ is a potent innate immune stimulator in vivo and ex vivo.
Mn
2+ Activates Anti-Viral Innate Immunity via the cGAS-
STING Pathway
Next we determined what underlies Mn 2+ -induced innate immune activation. Since we found that in low FBS concentrations HeLa cells exhibit a strong response to DNA (Wang et al., 2017) and MnCl 2 treatment ( Figure 4A ), we generated a series of genespecific deficient HeLa cells and C57BL/6 mice, using the CRISPR/Cas9 system ( Figure S4A ). We found that Mn 2+ -induced IRF3 phosphorylation, type I-IFN production and ISG induction were critically dependent on the integrity of the cGAS-STING pathway. Deficiency of any pivotal gene, namely MB21D1 for cGAS, TMEM173 for STING, TBK1, or IRF3 abrogated Mn ) or STING (Tmem173 À/À ) were used ( Figure 4C ).
Reconstitution of cGAS in cGAS-deficient cells restored Mn

2+
induced IRF3 phosphorylation and IFN production ( Figure S4B ). Mirroring the above observations, g2A, a JAK2-deficient HT1080 cell line that also lacks a functional endogenous cGAS, became sensitive to Mn 2+ treatment after stable expression of the Flagtagged cGAS ( Figure S4C ). In contrast to Mavs À/À and WT mice, MnCl 2 pretreatment did not provide any protection to Tmem173 À/À mice from virus infection ( Figures 4D and 4E ).
Similarly, Mn 2+ pretreatment did not confer STING-deficient cells resistance to virus (Figure S4D ), confirming that it was Mn-triggered cGAS-STING activation, but not Mn toxicity that inhibited virus.
Mn
2+ Activates cGAS-STING Independent of mtDNA Release Evidence suggested that excessive Mn accumulation leads to mitochondrial damage. Bak-and Bax-mediated mitochondrial DNA (mtDNA) release has been reported to activate the cGAS-STING pathway (Rongvaux et al., 2014; White et al., 2014) . We therefore tested whether mitochondrial damage-caused mtDNA leakage makes for the Mn 2+ -induced cGAS activation. We clarified that Mn 2+ treatment did not induce detectable cell death ( Figure 5A ) or apoptosis ( Figure 5B) at the concentrations causing prominent innate immune activation. In contrast, Bcl-2 inhibitor ABT-737 or ABT-263 robustly induced apoptosis as indicated by caspase-3/PARP1 cleavage, caspase-3/-7 activity, and genomic DNA fragmentation ( Figure 5B ). However, ABT-737/263-resistant Bak Figure 5C ) responded normally to Mn 2+ ( Figure 5D ), suggesting that Bakand Bax-mediated mtDNA escape may not be involved in Mn 2+ -induced cGAS-STING activation. Alternatively, Mn accumulation-induced excessive production of reactive oxygen species (ROS) has been implicated in mitochondrial damage (Martinez-Finley et al., 2013) , which induces mitochondrial permeability transition (MPT), characterized by the opening of permeability transition pores, and the collapse of inner mitochondrial membrane potential. To test whether ROS production played any role in Mn-induced cGAS-STING activation, several well-known anti-oxidants were used to assay their effects on Mn-induced type I-IFN production. We found that the inhibition of Mn-induced ROS production, indicated by DCFH-DA ROS probe, by pretreating cells with N-acetyl-L-cysteine (NAC, a direct scavenger of ROS) (Marreilha dos Santos et al., 2008) , reduced L-glutathione (GSH, the most crucial intracellular thiol antioxidant) or a-Tocopherol (Vitamin E, the most important lipophilic radical-scavenging antioxidant in vivo) (Niki, 2014) did not affect Mn-induced IRF3 phosphorylation, type I-IFN, and ISG production, indicating that ROS was not critically involved in the Mn 2+ -induced cGAS-STING activation ( Figure S5A ). Moreover, previous work showed that Mn accumulation resulted in MPT due to the opening of nonspecific pores in the inner mitochondrial membrane (IMM) followed by the rupture of outer membrane (OMM). MPT pore is usually formed by the VDAC-ANT-CYPD (voltage dependent anion channel-adenine nucleotide translocase -cyclophilin D) complex, located at the contact sites between IMM and OMM. The CYPD inhibitor Cyclosporin A (CsA) protects cells from MPT through its interaction with CYPD; N-ethylmaleimide (NEM) binds and inhibits ANT in MPT (Izzo et al., 2016) . So we tested whether any of these inhibitors would prevent Mn 2+ -induced MPT and immune activation.
We found that, agreeing with previous results, none of them have any inhibitory effect on ISG induction ( Figure S5B ). We also generated CYPD-deficient HeLa cells ( Figure S5D ) and found that CYPD À/À cells responded to Mn 2+ treatment as well as the wild-type cells ( Figure S5E ). Finally, we generated mtDNAdepleted cells in ethidium bromide-containing medium (Rongvaux et al., 2014; White et al., 2014) , which caused more than 70% and 90% of mtDNA lost in THP1 and HeLa cells, respectively ( Figures 5E and S5C, left) . Depletion of mtDNA completely abolished ABT-737/263-induced cGAS-STING activation in both cells with the caspase inhibitor z-VAD, whereas Mn 2+ -and VACV-induced cGAS-STING activation was not affected (Figures 5E and S5C, right) . These results collectively demonstrated that mtDNA is not implicated in Mn 2+ -induced cGAS-STING activation.
Mn 2+ Sensitizes and Activates cGAS and STING Mn 2+ activates many metal-enzymes by directly binding to enzymes. cGAS is a cyclase that generates cGAMP from ATP and GTP Civril et al., 2013; Gao et al., 2013; Sun et al., 2013; Figures S6A and S6B ), and both activation was dsDNA -dependent ( Figure S6C ). Nevertheless, only Mn 2+ triggered substantial type I-IFN production in cells ( Figure 6A ). Mn 2+ conferred cGAS a much higher enzymatic activity to produce more cGAMP with sufficient dsDNA (10 À2 mg/ml) in the presence or absence of Mg 2+ ( Figure 6B Figure S6D and data not shown). As the result, in vitro cGAS activation revealed that the sensitivity of cGAS to dsDNA increased nearly 10 4 times (10 À2 versus 10 À6 mg/ml) with Mn 2+ ( Figure 6D ). The more Mn 2+ in the reaction, the less dsDNA was required and more cGAMP was produced. Mutation of cGAS catalytic Mg 2+ -binding residues (Civril et al., 2013; Gao et al., 2013) abolished Mn 2+ -induced cGAMP production ( Figure 6D , Mt), suggesting (E) HeLa cells were cultured with or without 100 ng/ml ethidium bromide for 6 days. Depletion of mtDNA was measured by Quantitative PCR of mtDNA versus genomic DNA (left). Cells were treated with 200 mM MnCl 2 , 10 mM ABT-263 + 10 mM z-VAD (A263+z), 10 mM ABT-737 + 10 mM z-VAD (A737+z), or VACV for 18 hr, IRF3 phosphorylation and ISG production were monitored by western blot (right). One representative experiment of at least three independent experiments is shown, and each was done in triplicate. Data are shown as mean ± SEM (n R 3). ****p < 0.0001. See also Figure S5 .
is a steady dsDNA supply in the cytosol escaped from nuclei, mitochondria or lysosomes, or taken up from dying surrounding cells (Dombrowski et al., 2011; Lan et al., 2014) (E and F) HeLa cells were transfected with the indicated amounts of dsDNA (E); or THP1 cells were infected with the indicated dilutions of HSV-1 or VACV (F), 4 hr later fresh medium was changed with or without 50 mM MnCl 2 (E) or as indicated amounts of MnCl 2 (F). Supernatants were subjected to type I-IFN bioassay after 24 hr. One representative experiment of at least three independent experiments is shown, and each was done in triplicate. Data are shown as mean ± SEM (n R 3). ND, not detected; *p < 0.05; **p < 0.01; ***p < 0.001. See also Figure S6 .
ingredient open-source diets to establish a Mn-deficient mouse model. Two sets of weaning mice were fed ad libitum with the control chow diet (59 mg Mn/kg) or Mn-deficient diet (lower than 1 mg Mn/kg) for 6-8 weeks. Mice with Mn-deficient diet lived in a good healthy condition during this period of time, but showed at least 75% reduced Mn in various organs ( Figure 7A ). However, when challenged with virus, Mn-deficient micederived alveolar ( Figure 7B ) and peritoneal macrophages (Figures 7C and 7D) (E to G) The survival of indicated mice (E, n = 10-15; G, n = 12) and virus titers in the indicated organs (F, n = 10, 4 days after infection) of the control or Mn-deficient mice infected with a sub-lethal dose of VACV, HSV-1, or VSV (as described in the Methods).
(A and B) One representative experiment of at least three independent experiments is shown, and each was done in triplicate. (A, C, and F) Each dot point represents one independent biological replicate. Data are shown as mean ± SEM (n R 3). N.S., not significant, p > 0.05; *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001. See also Figure S7 .
caused by the lack of cellular Mn. Consequently, Mn-deficient wild-type mice were highly susceptible to a sub-lethal dose of HSV-1 or VACV challenge, as nearly all the Mn-deficient mice succumbed while all the control mice survived ( Figure 7E ). 10 3 times or higher virus titers were detected in organs of Mn-deficient mice ( Figure 7F ). Mn-deficient Tmem173 À/À mice showed no further increased susceptibility to virus compared with Mn-sufficient Tmem173 À/À mice ( Figures 7G and S7B ), confirming that it was cGAS-STING pathway that Mn 2+ synergically sensitized during virus infection. These results clearly demonstrated that Mn 2+ is required for the host defense against DNA virus in vivo.
DISCUSSION
Manganese is an essential constituent of many metalloenzymes and serves as an enzyme activator. The normal concentrations of Mn range from 0.072 mM to 0.27 mM in human blood (Aschner and Aschner, 2005) and from 20 mM to 53 mM in human brain (Bowman and Aschner, 2014) . We observed that THP1 cells, a cell line derived from peripheral blood, started to gain antiviral activity when the medium Mn 2+ level reached 2 mM. Thus, the concentrations of Mn 2+ required to activate innate immunity appeared to be within the physiological range. We further demonstrated that the cytosolic Mn levels increased 60 times to 5.8-6.8 mM after virus infection. Critically, Mn 2+ supported cGAS to produce cGAMP with low levels of dsDNA while Mg 2+ didn't at all. The elevated cytosolic Mn 2+ thus significantly lowered the detection limit of cells to cytosolic dsDNA or DNA viruses. Accordingly, Mn-deficient mice were highly susceptible to DNA virus as Tmem173 À/À mice did. Accumulation of extracellular soluble Mn was also observed. It is conceivable that the extracellular Mn was released by virus-infected cells, both alive and pyroptotic. In fact, the increased Mn contents in bronchoalveolar lavage fluid, white blood cells, and alveolar macrophages in virus-infected mice confirmed the physiological relevance of the Mn extracellular release, suggesting that Mn alerts host both locally at the site of infection and systemically through the circulation. Interestingly, Burleson's group reported that a single intraperitoneal injection of 10, 20, or 40 mg MnCl 2 /g body weight caused significantly enhanced NK activity, probably mediated by the production of type I-IFNs (Smialowicz et al., 1988) . Although the amount of Mn used in that work was 10 times higher than what we used (10-40 mg versus 1-2 mg MnCl 2 /g body weight), we believe that it was most likely through the cGAS-STING activation. in vitro in almost half of Mg 2+ -dependent enzymes, in which the catalytic activity of the enzymes are often maintained (Wedler, 1993) . In this study, however, we found that Mn 2+ not only replaces Mg 2+ in cGAS activation, but also enhances its enzymatic activity and ligand sensitivity. Similar results have been reported in the insulin receptor associated protein kinase, the kinase activity of which was activated substantially by Mn 2+ , but not by Mg 2+ (Suzuki et al., 1987; Wente et al., 1990 may induce cGAS protein into a compact conformation which is easier to be activated. Unfortunately, this feature disallowed us to test the interaction of cGAS with ATP, GTP, or dsDNA in the presence of Mn 2+ . In addition, Mn 2+ promoted STING activation through the enhanced cGAMP-STING affinity. This result agreed with previous work showing that Mn 2+ promotes the dimerization of c-di-GMP and 3 0 3'-cGAMP (Roembke et al., 2014; Stelitano et al., 2013) .
Mn is the only essential metal of which the transportation and the subcellular distribution in organelles are not defined (Horning et al., 2015; Kwakye et al., 2015) . We found that upon DNA virus infection, Mn 2+ is liberated from mitochondria and/or Golgi apparatus, the major intracellular reservoirs for Mn 2+ storage. In addition, free Mn 2+ may also be released from Mn-binding proteins such as metallothioneins and calprotectin, an Mn 2+ -sequestering protein constituting about 40% of the total cytoplasmic protein in neutrophils (Brophy and Nolan, 2015) , and/or albumin, the major Mn 2+ -binding protein in plasma (Foradori et al., 1967; Rabin et al., 1993) . The released Mn 2+ from organelles and Mn
2+
-binding proteins altogether leads to the elevated cytosolic Mn 2+ and the activation of cGAS-STING pathway. However, excessive exposure or accumulation of Mn is harmful to the central nervous system due to its preferential Mn uptake by the brains and spinal cords. It is reported that Manganism occurs in response to acute Mn exposures, while Parkinsonism may result from long-term exposure to low levels of Mn (Martinez-Finley et al., 2013) . In fact, the cellular toxicity of Mn (mainly exerted by Mn 2+ ) has long been recognized and attributed to multiple mechanisms, nevertheless the molecular basis is still inconclusive, or even contradictory in some cases (Horning et al., 2015) . In particular, elevated type I-IFNs were implicated in the development of Parkinson's disease. In some extreme cases, type I-IFN treatment caused severe Parkinsonism that was resolved after interferon withdrawal (Mizoi et al., 1997; Sarasombath et al., 2002) . We showed that Mn 2+ accumulation causes prominent innate immune activation, leading to the production and secretion of cytokines. Such pathological immune activation in the central nervous system will certainly contribute to the cellular and tissue damage, culminating in Manganism and Parkinsonism. These findings therefore may provide new insights into the molecular basis underlying the development of Manganism, in which Mn-caused toxicity has long been recognized. New therapeutic attempts should focus to prevent this detrimental immune activation in the central nervous system.
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is the metazoan second messenger produced by DNA-activated cyclic GMP-AMP synthase. Cell 153, 1094-1107.
Gavin, C.E., Gunter, K.K., and Gunter, T.E. (1990 Human cGAS expression and purification cDNAs of full-length (1-522) and mutant (E225A/D227A) human cGAS (hcGAS) were cloned into pET-21b vector. The recombinant His 6 -hcGAS were expressed in E. coli BL21 (DE3) with 0.3 mM isopropyl b-D-1-thiogalactopyranoside (IPTG) induction overnight at 18 C. Cells were lysed in lysis buffer (25 mM Tris-HCl, 500 mM NaCl, pH 7.5) and cell debris was removed by centrifugation at 20, 000 g for 1 h. The supernatant was filtered through a 0.2 mm low protein binding membrane (Pall Corporation). Cleared supernatant was loaded onto HisTrap HP column (GE Healthcare) and eluted with an imidazole gradient of 0 to 300 mM in the lysis buffer. The proteins were treated with 1 U/ml Benzonase (Sigma) overnight to eliminate DNA and RNA. 2 mM EDTA was added to remove the divalent cations. After that, the proteins went through gel filtration on Superdex 200 column (GE Healthcare) equilibrated with lysis buffer. Finally, the purified proteins were concentrated to 10 mg/ml using Amicon Ultra-4 10K centrifugal filter (Merck Millipore).
cGAS-cGAMP Activity Assay cGAS activity was analyzed as described previously (Sun et al., 2013; . Purified recombinant full-length hcGAS was incubated in 500 mL reaction containing: 2 mM hcGAS, 0.2 mM ATP, 0.2 mM GTP, 100 mM NaCl, 40 mM Tris-HCl pH 7.5 and 0.25-1 mM MnCl 2 or 2.5-10 mM MgCl 2 at 37 C for 2 h (with 10 À2 mg/ml dsDNA) or 6 h (with 10 À4 mg/ml dsDNA). Reactions were heated at 99 C to denature proteins and centrifuged at 16, 000 g for 10 min. The supernatants were analyzed on a Mono Q ion exchange column (GE Healthcare) equilibrated with running buffer (50 mM Tris-HCl, pH 8.5) and eluted with the gradient of NaCl from 0 to 500 mM (Related to Figure 6B ).
For cGAMP activity in MB21D1 À/À HeLa cells, 6 3 10 5 cGAS-deficient HeLa cells were incubated in 200 mL reactions containing: 100 mM NaCl, 40 mM Tris-HCl pH 7.5, 10 mg/ml digitonin, 0.4 or 2 mM cGAMP and 0.1-1 mM MnCl 2 or 1-10 mM MgCl 2 at 37 C for 30 min. Cells were lysed to perform western blot to measure cGAMP-induced IRF3 and STING phosphorylation (Related to Figure 6C ).
Otherwise, purified recombinant full-length or mutant hcGAS was incubated in 40 mL reaction containing: 1 mM hcGAS, 1 mM ATP, 1 mM GTP, 100 mM NaCl, 40 mM Tris-HCl pH 7.5, 10 À2 -10 À6 mg/ml dsDNA or 10 À2 mg/ml polynucleotide and 0.05-1 mM MnCl 2 or 0.5-10 mM MgCl 2 at 37 C for 30 min. Reactions were added with 10 mg/ml digitonin and 6 3 10 5 THP1 cells, and then incubated at 37 C for 30 min. Cells were lysed to perform western blot to measure cGAMP-induced IRF3 phosphorylation (Related to Figure 6D , S6B and S6C).
Isothermal Titration Calorimetry (ITC)
The dissociation contents were measured by ITC with a PEAQ ITC instrument (Malvern) at 25 C. Human STING protein (155-341) was purified by nickel affinity chromatography, followed by gel filtration chromatography and eluted in lysis buffer (30 mM HEPES, 150 mM NaCl, pH 7.0). cGAMPs (0.5 mM 2 0 3 0 -cGAMP in the syringe, 18 3 2 mL injections) and hSTING (0.1 mM STING in the reaction cell with 0.18 mM c-di-GMP) was operated in the presence of MnCl 2 or MgCl 2 with a reference offset of 5 mcal/s, a syringe stirring speed of 750 rpm, a pre-injection delay of 60 s, and a 150 s interval between injections. Data were analyzed with Origin 7 (Microcal).
Mitochondrial DNA Depletion
HeLa cells were cultured in DMEM (GIBCO) supplemented with 10% FBS (GIBCO), 4 mM L-glutamine, 4.5 g/l glucose, 100 mg/ml sodium pyruvate, 50 mg/ml uridine and 100 ng/ml ethidium bromide for 6 days as described (Hashiguchi and Zhang-Akiyama, 2009; King and Attardi, 1989) . THP1 cells were cultured in RPMI-1640 (GIBCO) supplemented with 20% FBS (GIBCO), 100 mg/ml sodium pyruvate, 50 mg/ml uridine and 25 ng/ml ethidium bromide for 4 days. Depletion of mtDNA was measured by Quantitative PCR of mtDNA versus genomic DNA.
RT-PCR and Quantitative RT-PCR Analysis
Total RNA was isolated using TRIzol reagent (Invitrogen), according to the manufacturer's instruction. One microgram of total RNA was converted into cDNA with random primer and Superscript III reverse transcriptase (Invitrogen). PCR was performed with gene-specific primer sets. The RT-PCR products were resolved on a 1.5% agarose gel and visualized by ethidium bromide staining. Quantitative real-time PCR was performed with Sybr green incorporation on the LightCyclerÒ 96 System (Roche), and the data were presented as accumulation index (2 DDCt ).
Measurement of Cell Viability
The cell viability was measured through MTT (3-(4, 5-dimethylthiazol-2-yl)-2, 5 -diphenyltetrazolium bromide) assay by using Vybrant MTT Cell Proliferation Assay Kit (Invitrogen, V13154) according to manufacturer's instructions.
Apoptosis Analysis
For DNA fragmentation assay, 10 5 THP1 cells were re-suspended in 500 mL buffer D (100 mM Tris-HCl pH 8.0, 5 mM EDTA, 0.2 M NaCl, 0.4% SDS, 0.2 mg/ml proteinase K) and incubated at 37 C overnight. DNA was deproteinized with phenol and phenol-chloroform (1:1) and precipitated with 2 volumes of ethanol. DNA precipitate was re-suspended in 15 mL TE buffer (pH 8.0) with 1 mg/ml RNase. After incubation at 37 C for 2 h, the DNA was loaded onto a 1% agarose gel, electrophoresed and visualized by staining with ethidium bromide and illumination with short-wavelength ultraviolet light.
Apoptosis was evaluated by Annexin V-fluorescein isothiocyanate (FITC) and propidium iodide (PI) Apoptosis Detection Kit (Solarbio, CA1020) according to manufacturer's instructions.
Caspase-3/-7 activation was measured by the Caspase-GloÒ 3/7 Assay kit (Promega, G8090) according to manufacturer's instructions.
Reactive Oxygen Species (ROS) detection THP1 cells were pre-treated with 2 mM N-acetyl-L-cysteine (NAC), 2 mM L-Glutathione reduced (GSH Reduced) or 20 mM a-Tocopherol for 2 h. Then cells were treated with or without 200 mM MnCl 2 . Intracellular ROS was determined by Reactive Oxygen Species Assay Kit (Solarbio, CA1410) through DCFH-DA ROS probe according to the manufacturer's instructions.
Diet-Induced Manganese Deficiency
Weaning C57BL/6 mice were randomly divided into 2 dietary groups and fed with either the control diet AIN-76A (D10001, with 59.34 ppm Manganese) or AIN-76A without added manganese (D18901, with Manganese lower than 1 ppm), obtained from Research Diets Inc. (New Brunswick, U.S.A.) for 6-8 weeks. Feed consumption and body weight of the mice were measured every week. Mice were sacrificed by carbon dioxide asphyxiation followed with cervical dislocation. Liver, lung, and intestine tissues were excised immediately after euthanasia, flash frozen in liquid nitrogen, and stored at À80 C for later use. Peritoneal macrophages were harvested from mice 5 days after thioglycollate (BD) injection, and resuspended in the Opti-MEM medium (GIBCO) without FBS. After seeded on 24 or 6-well plates for 30 min, cells were infected with SeV (MOI of 0.01), VACV (Western Reserve-Vvt7 strain, MOI of 0.01), or HSV-1 (F strain, MOI of 0.01) for 1 h, rinsed and cultured in fresh medium without FBS for 24 h. qRT-PCR and western blot analysis of gene expression in peritoneal macrophages from the control or Mn-deficient mice were performed. In the Mn-rescue experiment, MnCl 2 was added into the serum-free Opti-MEM medium 6 h before cells were infected with different viruses.
QUANTIFICATION AND STATISTICAL ANALYSIS
The Student's t test was used to analyze data. The compared two groups were labeled by square brackets. The ANOVA test was used to analyze experiments involving multiple tests and variables. Survival curves were compared using the Mantel-Cox test. For the bar graph, one representative experiment of at least three independent experiments is shown, and each was done in triplicate. For the dot plot graph, each dot point represents one independent biological replicate. Data are shown as mean ± SEM (n R 3). N.S., not significant, p > 0.05; *p < 0.05; ** p < 0.01; ***p < 0.001; ****p < 0.0001.
DATA AND SOFTWARE AVAILABILITY
RNA-seq data have been deposited in Gene Expression Omnibus under accession number GSE77216.
